Hovione is an international developer and manufacturer of active pharmaceutical ingredients, with extensive capabilities in cGMP spray-drying across all scales. With four FDA inspected sites in the U.S., China, Ireland, and Portugal, the company focuses on the most demanding customers, in the most regulated markets. Hovione has experience at taking projects through QbD filings all the way to successful NDA approval and commercial launch.

The company also offers integrated API, particle design and formulation development and manufacturing. In the inhalation area, Hovione is the only independent company offering such a broad range of services. Hovione employs 1,200 people worldwide and has more than 1300m3 of flexible production capacity.